Jerome Dvonch
Director of Finance/CFO bei SONOMA PHARMACEUTICALS, INC.
Vermögen: 2 574 $ am 31.03.2024
Aktive Positionen von Jerome Dvonch
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SONOMA PHARMACEUTICALS, INC. | Director of Finance/CFO | 08.09.2020 | - |
Karriereverlauf von Jerome Dvonch
Ehemalige bekannte Positionen von Jerome Dvonch
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SONOMA PHARMACEUTICALS, INC. | Director of Finance/CFO | 08.09.2020 | 03.10.2022 |
NeoGenomics Laboratories, Inc.
 NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | Director of Finance/CFO | 01.07.2005 | 01.07.2015 |
Protein Design Labs, Inc.
 Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | Corporate Officer/Principal | 01.06.2004 | 01.07.2005 |
| EXELIXIS, INC. | Corporate Officer/Principal | 01.09.2000 | 01.06.2004 |
| Spine Center Atlanta | Comptroller/Controller/Auditor | 01.03.2017 | - |
| PHARMCHEM, INC. | Corporate Officer/Principal | - | - |
| NEOGENOMICS, INC. | Comptroller/Controller/Auditor | 01.08.2005 | - |
| Director/Board Member | 23.05.2011 | - | |
| Director of Finance/CFO | 05.04.2010 | 25.02.2011 |
Ausbildung von Jerome Dvonch
| Rochester Christian University | Masters Business Admin |
| Niagara University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 10 |
Operativ
| Director of Finance/CFO | 4 |
| Corporate Officer/Principal | 3 |
| Comptroller/Controller/Auditor | 2 |
Sektoral
| Health Technology | 4 |
| Health Services | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| PHARMCHEM, INC. | Health Services |
| NEOGENOMICS, INC. | Health Services |
| EXELIXIS, INC. | Health Technology |
| SONOMA PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | Health Technology |
NeoGenomics Laboratories, Inc.
NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | Health Services |
| Spine Center Atlanta |
- Börse
- Insiders
- Jerome Dvonch
- Erfahrung
